Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
Pregnancy in multiple sclerosis: a questionnaire study.
Substance Name: Riluzole
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Regression-Based Norms Improve the Sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Effects of phenytoin on the persistent Na+ current of mammalian CNS neurones.
Prognostic indicators for long-term disability in multiple sclerosis patients.
Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
Estimating the proportion of variation in susceptibility to multiple sclerosis captured by common SNPs.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation.
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis.
Selective depression of low-release probability excitatory synapses by sodium channel blockers.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Gammaherpesvirus Latency Accentuates EAE Pathogenesis: Relevance to Epstein-Barr Virus and Multiple Sclerosis.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
202
203
204
205
206
207
208
209
210
…
next ›
last »